Related Experiment Videos
Eccentric LVH healing after starting renal replacement therapy.
Ugo Vertolli1, Mario Lupia, Agostino Naso
1Division of Nephrology, Hospital of Padova, Padua, Italy.
Journal of Nephrology
|September 24, 2002
Summary
Standard hemodialysis effectively reversed severe left ventricular hypertrophy and mitral incompetence in a patient with chronic renal failure (CRF). This highlights the impact of managing uremic toxicity on cardiac function.
Area of Science:
- Nephrology
- Cardiology
- Internal Medicine
Background:
- Hypertension and left ventricular hypertrophy (LVH) are common in patients with chronic renal failure (CRF) undergoing regular dialysis therapy (RDT).
- Eccentric LVH with significant left ventricular dilatation and mitral regurgitation is a recognized complication.
Observation:
- A 62-year-old female patient starting hemodialysis (HD) presented with dyspnea and echocardiographic findings of dilated left atrium, moderately dilated left ventricle with normal systolic function, increased ventricular mass, and grade +3/4 mitral incompetence.
- After three months of standard RDT and a modest weight reduction, the patient became normotensive without medication.
Findings:
- Hemodynamic and echocardiographic studies revealed a normalized left ventricle with preserved systolic function and complete resolution of mitral regurgitation.
- Coronary angiography showed no critical stenosis, suggesting the cardiac changes were primarily related to hypertensive cardiomyopathy and uremic toxicity.
Implications:
- This case demonstrates that alleviating uremic toxicity through effective hemodialysis can significantly ameliorate cardiac performance, including reversing structural changes like LVH and functional issues like mitral incompetence.
- The findings suggest a potential for improving cardiovascular outcomes in CRF patients by optimizing dialysis therapy and managing associated toxicities.